HIV/AIDS News and Research RSS Feed - HIV/AIDS News and Research Twitter

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

This condition progressively reduces the effectiveness of the immune system and leaves individuals susceptible to opportunistic infections and tumors. HIV is transmitted through direct contact of a mucous membrane or the bloodstream with a bodily fluid containing HIV, such as blood, semen, vaginal fluid, preseminal fluid, and breast milk.
Simple low-cost intervention could help reduce HIV-related deaths in Africa

Simple low-cost intervention could help reduce HIV-related deaths in Africa

A new approach to care for patients with advanced HIV in Tanzania and Zambia, combining community support and screening for a type of meningitis, has reduced deaths by 28%. [More]
Clinical study launched to evaluate effectiveness of new HCV therapy in Washington, D.C.

Clinical study launched to evaluate effectiveness of new HCV therapy in Washington, D.C.

Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection. [More]
Lifestyle intervention program at workplace reduces risk factors for diabetes, heart disease

Lifestyle intervention program at workplace reduces risk factors for diabetes, heart disease

A healthy lifestyle intervention program administered at the workplace and developed by the University of Pittsburgh Graduate School of Public Health significantly reduces risk factors for diabetes and heart disease, according to a study reported in the March issue of the Journal of Occupational and Environmental Medicine. [More]
Women for Positive Action introduces new educational tool for women living with HIV

Women for Positive Action introduces new educational tool for women living with HIV

To mark International Women's Day (March 8, 2015), Women for Positive Action has launched a practical and informative new educational tool entitled 'Hepatitis and coinfection in women living with HIV'. Led by a global, multidisciplinary group of experts, Women for Positive Action is committed to addressing the specific concerns of women living with HIV. [More]
WuXi applauds TaiMed for receiving FDA breakthrough therapy designation for ibalizumab

WuXi applauds TaiMed for receiving FDA breakthrough therapy designation for ibalizumab

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, congratulates our partner TaiMed Biologics for receiving breakthrough therapy designation from the U.S. FDA for ibalizumab (TMB355). [More]

Mylan acquires non-U.S. developed markets specialty and branded generics business from Abbott

Mylan N.V. and Mylan Inc. today announced the successful completion of the acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business. [More]
ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

ABIVAX, a clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced that it has dosed in New Zealand the first patient in a Phase IIb/III clinical trial of ABX203 which is taking place in several countries of the Asia-Pacific region. [More]

MPP, MSD sign licensing agreement for paediatric formulations of raltegravir

The Medicines Patent Pool announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with HIV four weeks of age and older. [More]
Mylan to distribute Sovaldi and Harvoni tablets in India for treatment of chronic hepatitis C

Mylan to distribute Sovaldi and Harvoni tablets in India for treatment of chronic hepatitis C

Mylan Inc. today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India. [More]
Case Western dental researcher discovers new way to model how T cells cause inflammation in mice

Case Western dental researcher discovers new way to model how T cells cause inflammation in mice

Case Western Reserve University dental researcher Pushpa Pandiyan has discovered a new way to model how infection-fighting T cells cause inflammation in mice. [More]
Scientists develop promising new HIV vaccine agent

Scientists develop promising new HIV vaccine agent

In a study that involved researchers from over a dozen institutions, the anti-HIV agent protected monkeys from every strain of HIV-1, HIV-2 and SIV (simian immunodeficiency virus) for at least 34 weeks. [More]
Natalizumab drug helps scientists confirm how 'viral reservoirs' form in HIV patients

Natalizumab drug helps scientists confirm how 'viral reservoirs' form in HIV patients

A drug used to treat patients with Crohn's disease and multiple sclerosis has helped scientists confirm how "viral reservoirs" form in patients living with HIV and also proven effective in animal trials at blocking the pathways to those reservoirs in the brain and gut, a team of researchers reported recently in the journal PLOS Pathogens. [More]
New clinical trial launched in South Africa to study investigational HIV vaccine regimen

New clinical trial launched in South Africa to study investigational HIV vaccine regimen

A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program-led RV144 clinical trial in Thailand--the first study to demonstrate that a vaccine can protect people from HIV infection. [More]
San Francisco AIDS Foundation unveils new mobile testing unit

San Francisco AIDS Foundation unveils new mobile testing unit

On Valentine's Day, San Francisco AIDS Foundation unveiled a new mobile testing unit, an essential element in the plan to eliminate HIV transmission in San Francisco. The new unit—a 33-foot-long vehicle outfitted specifically for HIV and STI testing—will increase the availability of free testing in neighborhoods across the city at times when other HIV testing sites are closed. [More]
UNICEF and UNAIDS go ‘All In’ to end the AIDS epidemic among adolescents

UNICEF and UNAIDS go ‘All In’ to end the AIDS epidemic among adolescents

AIDS has become the second leading cause of death among adolescents globally. Just one in four children and adolescents under the age of 15 have access to life-saving antiretroviral treatment. Deaths are declining in all age groups, except among 10–19 year olds. [More]
Report: Proposed SDGs may not achieve policy objectives without clearer, more measurable targets

Report: Proposed SDGs may not achieve policy objectives without clearer, more measurable targets

The proposed UN Sustainable Development Goals (SDGs) - a universal set of goals to guide international development to 2030 - will struggle to achieve their stated policy objectives without clearer, more measurable targets, according to a new report released today by the International Council for Science and the International Social Science Council. [More]
Centene Foundation for Quality Healthcare awards grants to support MIHS programs

Centene Foundation for Quality Healthcare awards grants to support MIHS programs

The Centene Foundation for Quality Healthcare announced today that it awarded $50,000 in community impact grants to help four programs that support the underserved, including a unique hospital-based domestic violence prevention effort. [More]
Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015. [More]
Harborview's MCICU receives gold-level Beacon Award for Excellence from AACN

Harborview's MCICU receives gold-level Beacon Award for Excellence from AACN

Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses. [More]
UC San Diego School of Medicine project receives 2015 Avant-Garde Award for HIV/AIDS Research

UC San Diego School of Medicine project receives 2015 Avant-Garde Award for HIV/AIDS Research

A University of California, San Diego School of Medicine project involving the creation of miniature models of the human brain - developed with stem cells - to study neurological disorders caused by HIV and methamphetamine use has been named one of five recipients of the 2015 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse. [More]
Advertisement